No picture, placeholder image
No picture, placeholder image
Department of Medical Biology lro037@post.uit.no +4777625182 Tromsø

Leif R. Rønning


DVM, Ph.D.-student cardiovascular research group


  • Lars Rødland, Leif Reidar Brenk Rønning, Anders Benjamin Kildal, Ole-Jakob How :
    The β3 adrenergic receptor antagonist L-748,337 attenuates dobutamine-induced cardiac inefficiency while preserving inotropy in anesthetized pigs
    Journal of Cardiovascular Pharmacology and Therapeutics 23. September 2021 ARKIV / DOI
  • Lars Rødland, Leif Reidar Brenk Rønning, Anders Benjamin Kildal, Truls Myrmel, Ole-Jakob How :
    Combined therapy with dobutamine and omecamtiv mecarbil in pigs with ischemic acute heart failure is attributed to the effect of dobutamine
    Journal of Cardiovascular Pharmacology and Therapeutics 2019 ARKIV / DOI
  • Leif Reidar Brenk Rønning, Jens Petter Bakkehaug, Lars Rødland, Anders Benjamin Kildal, Truls Myrmel, Ole-Jakob How :
    Opposite diastolic effects of omecamtiv mecarbil versus dobutamine and ivabradine co-treatment in pigs with acute ischemic heart failure
    Physiological Reports 2018 ARKIV / DOI
  • Jens Petter Bakkehaug, Anders Benjamin Kildal, Erik Torgersen Engstad, Neoma Tove Boardman, Torvind Næsheim, Leif R. Rønning et al.:
    Myosin activator omecamtiv mecarbil increases myocardial oxygen consumption and impairs cardiac efficiency mediated by resting myosin ATPase activity
    Circulation: Heart Failure 2015 DOI
  • Jens Petter Bakkehaug, Anders Benjamin Kildal, Erik Torgersen Engstad, Neoma Tove Boardman, Torvind Næsheim, Leif R. Rønning et al.:
    Response to Letter Regarding Article, "Myosin Activator Omecamtiv Mecarbil Increases Myocardial Oxygen Consumption and Impairs Cardiac Efficiency Mediated by Resting Myosin ATPase Activity"
    Circulation: Heart Failure 2015 DOI

  • The 50 latest publications is shown on this page. See all publications in Cristin here →